Core Viewpoint - Ark Health has successfully raised HKD 150 million through a share placement at a price of HKD 3.32 per share, representing approximately 3.26% of the company's expanded issued share capital [1] Group 1: Fund Utilization - The company plans to allocate approximately 90% of the net proceeds, around HKD 129 million, to accelerate the development of its "AI + Chronic Disease Management" platform [1] - The funds will be used for model development and optimization, expansion of infrastructure and computing resources, recruitment of AI and clinical professionals, data collection and annotation, and knowledge base construction [1] - The company aims to launch AI-enhanced services to cover a broader range of patients and healthcare professionals [1]
方舟健客成功获配1.5亿港币，每股配售价为3.32港元